Listed by the USPTO as RODRIGUEZ, RAYNA B
Tech Center 1600 • Art Units: 1628 1692
This examiner grants 34% of resolved cases
RODRIGUEZ, RAYNA B is assigned to USPTO Tech Center 1600 and art unit 1628. The profile covers 587 resolved cases and reports a 33.6% allowance rate. Interviews show a 19.2% lift in allowance outcomes. The median time to allowance is 1264 days, indicating that matters in this record may require an extended path to disposition.
The listed companies are Genentech Inc., Deciphera Pharmaceuticals LLC, and Bayer Aktiengesellschaft. The listed firms are COOLEY LLP, Sheppard, Mullin, Richter & Hampton LLP, and ARENTFOX SCHIFF LLP. The lower allowance rate supports careful preparation of claim scope and evidentiary support. The positive interview measure suggests that examiner discussions may assist, but should be coordinated with a strong written prosecution position.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18685717 | NOVEL PYRAZINYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Non-Final OA | Bayer Aktiengesellschaft |
| 17251452 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | Non-Final OA | NeOnc Technologies, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.6% of resolved applications examined by Rayna B Rodriguez were allowed (587 resolved cases), compared with 26.0% across Art Unit 1628 over the last five years.
This examiner's interview lift is +19.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rayna B Rodriguez took 1,264 days on average from filing to allowance.
Rayna B Rodriguez examines applications in Art Unit 1628 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
